Serum AADC enzyme activity was evaluated in a discovery cohort and validated in two independent cohorts of patients with PD or parkinsonism (n = 301) and compared between patients on levodopa/PDI (n = 140) vs. patients not on this medication (n = 161). Here, DDC is linked to Parkinson disease.